Evaluating Biomaterial- and Microfluidic-Based 3D Tumor Models

Trends in Biotechnology

Volumn 33, Issue 11, 2015, Pages 667-678

  Carvalho, Mariana R ^a   Lima, Daniela ^a   Reis, Rui L ^a   Correlo, Vitor M ^a   Oliveira, Joaquim M ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

Biomaterials; Cancer microenvironment; Drug discovery; Microfluidics

Indexed keywords

BIOMATERIALS; CELL CULTURE; DISEASES; TISSUE ENGINEERING;

3D TISSUE ENGINEERINGS; CLINICAL APPLICATION; DISEASE BURDENS; DRUG DISCOVERY; LIMITED INFORMATION; MICROENVIRONMENTS; MICROFLUIDIC-BASED; STATE OF THE ART;

MICROFLUIDICS;

BIOMATERIAL;

ADVANCED CANCER; ANGIOGENESIS; BIOCOMPATIBILITY; CANCER RESEARCH; DRUG DEVELOPMENT; EVALUATION STUDY; HUMAN; IN VITRO STUDY; LAB ON A CHIP; METASTASIS; MICROFLUIDICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TISSUE SCAFFOLD; TUMOR MICROENVIRONMENT; TUMOR MODEL; BIOLOGICAL MODEL; NEOPLASM; PATHOPHYSIOLOGY; PROCEDURES;

HUMANS; MICROFLUIDICS; MODELS, BIOLOGICAL; NEOPLASMS; TISSUE ENGINEERING;

EID: 84947599454     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2015.09.009     Document Type: Review

References (104)

1. Albini A., Sporn M.B. The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer 2007, 7:139-147.
2. Fang X., et al. Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer. PLoS ONE 2013, 8:e75187.
3. Gurski L.A., et al. Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 2009, 30:6076-6085.
4. Cheema U., et al. Spatially defined oxygen gradients and vascular endothelial growth factor expression in an engineered 3D cell model. Cell. Mol. Life Sci. 2008, 65:177-186.
5. Kenny P.A., Bissell M.J. Targeting TACE-dependent EGFR ligand shedding in breast cancer. J. Clin. Invest. 2007, 117:337-345.
6. Kurisu S., et al. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 2005, 24:1309-1319.
7. Ridky T.W., et al. Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia. Nat. Med. 2010, 16:1450-1455.
8. Wozniak M.A., et al. Focal adhesion regulation of cell behavior. Biochim. Biophys. Acta. 2004, 1692:103-119.
9. Hsiao A.Y., et al. Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids. Biomaterials 2009, 30:3020-3027.
10. Jason E.E., et al. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro: implication for drug development. PLoS ONE 2014, 9:e92248.
11. Elliott N.T., Yuan F. A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J. Pharm. Sci. 2011, 100:59-74.
12. Rimann M., Graf-Hausner U. Synthetic 3D multicellular systems for drug development. Curr. Opin. Biotechnol. 2012, 23:803-809.
13. Peck Y., Wang D.A. Three-dimensionally engineered biomimetic tissue models for in vitro drug evaluation: delivery, efficacy and toxicity. Expert Opin. Drug Delivery 2013, 10:369-383.
14. Mano J.F. Designing biomaterials for tissue engineering based on the deconstruction of the native cellular environment. Mater. Lett. 2015, 141:198-202.
15. Loessner D., et al. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 2010, 31:8494-8506.
16. Schmeichel K.L., Bissell M.J. Modeling tissue-specific signaling and organ function in three dimen. et al. (2008) p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer. Neoplasia 2003, 10:314-329.
17. Li Q., et al. p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer. Neoplasia 2008, 10:314-329.
18. Weaver V.M., et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 1997, 137:231-245.
19. Kleinman H.K., et al. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 1982, 21:6188-6193.
20. Terranova V.P., et al. Regulation of cell attachment and cell number by fibronectin and laminin. J. Cell. Physiol. 1986, 127:473-479.
21. Lee G.Y., et al. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 2007, 4:359-365.
22. Wong A.P., et al. Partitioning microfluidic channels with hydrogel to construct tunable 3-D cellular microenvironments. Biomaterials 2008, 29:1853-1861.
23. Kalabis J., et al. Stimulation of human colonic epithelial cells by leukemia inhibitory factor is dependent on collagen-embedded fibroblasts in organotypic culture. FASEB J. 2003, 17:1115-1117.
24. Szot C.S., et al. 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials 2011, 32:7905-7912.
25. Liu J., et al. Soft fibrin gels promote selection and growth of tumorigenic cells. Nat. Mater. 2012, 11:734-741.
26. Silva-Correia J., et al. Angiogenic potential of gellan-gum-based hydrogels for application in nucleus pulposus regeneration: in vivo study. Tissue Eng. Part A 2012, 18:11-12.
27. Yan L.P., et al. Bilayered silk/silk-nanoCaP scaffolds for osteochondral tissue engineering: In vitro and in vivo assessment of biological performance. Acta Biomater 2015, 12:227-241.
28. Yan L.P., et al. In vitro evaluation of the biological performance of macro/micro-porous silk fibroin and silk-nano calcium phosphate scaffolds. J. Biomed. Mater. Res. B: Appl. Biomater. 2015, 103:888-898.
29. Yan L.P., et al. Bilayered silk/silk-nanoCaP scaffolds for osteochondral tissue engineering: In vitro and in vivo assessment of biological performance. Acta Biomater. 2015, 12:227-241.
30. Khang G., et al. Biological evaluation of intervertebral disc cells in different formulations of gellan gum-based hydrogels. J. Tissue Eng. Regen. Med. 2015, 9:265-275.
31. Phan-Lai V., et al. Three-dimensional scaffolds to evaluate tumor associated fibroblast-mediated suppression of breast tumor specific T cells. Biomacromolecules 2013, 14:1330-1337.
32. Chung B.G., et al. Microfluidic fabrication of microengineered hydrogels and their application in tissue engineering. Lab Chip 2012, 12:45-59.
33. Chen Y.A., et al. Generation of oxygen gradients in microfluidic devices for cell culture using spatially confined chemical reactions. Lab Chip 2011, 11:3626-3633.
34. Inamdar N.K., Borenstein J.T. Microfluidic cell culture models for tissue engineering. Curr. Opin. Biotechnol. 2011, 22:681-689.
35. Zhou Y., Lin Q. Microfluidic flow-free generation of chemical concentration gradients. Sensors Actuators B: Chem. 2014, 190:334-341.
36. Choi Y., et al. Three dimensional MEMS microfluidic perfusion system for thick brain slice cultures. Biomed. Microdevices 2007, 9:7-13.
37. Toh Y.C., et al. A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab Chip 2007, 7:302-309.
38. Zhang W., et al. Patient-specific 3D microfluidic tissue model for multiple myeloma. Tissue Eng. C: Methods 2014, 20:663-670.
39. Chrobak K.M., et al. Formation of perfused, functional microvascular tubes in vitro. Microvasc. Res. 2006, 71:185-196.
40. Young E.W. Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment. Integr. Biol. 2013, 5:1096-1109.
41. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307:58-62.
42. Bergers G., et al. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 2003, 111:1287-1295.
43. Seo B.R., et al. In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer. Adv. Drug Deliv. Rev. 2014, 69-70:205-216.
44. Nguyen D.H., et al. Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:6712-6717.
45. Miller J.S., et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat. Mater. 2012, 11:768-774.
46. Buchanan C.F., et al. Three-dimensional microfluidic collagen hydrogels for investigating flow-mediated tumor-endothelial signaling and vascular organization. Tissue Eng. C: Methods 2014, 20:64-75.
47. Moya M., et al. An integrated in vitro model of perfused tumor and cardiac tissue. Stem Cell Res. Ther. 2013, 4(Suppl. 1):S15.
48. Harris D.T. Hormonal therapy and chemotherapy of renal-cell carcinoma. Semin. Oncol. 1983, 10:422-430.
49. Shablak A., et al. T cell-based immunotherapy of metastatic renal cell carcinoma: modest success and future perspective. Clin. Cancer Res. 2009, 15:6503-6510.
50. Pouliot N., et al. Investigating metastasis using in vitro platforms. Metastatic Cancer: Clinical and Biological Perspectives (Jandial R.), Landes Bioscience 2000.
51. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
52. Zervantonakis I.K., et al. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:13515-13520.
53. Bersini S., et al. A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. Biomaterials 2014, 35:2454-2461.
54. Xu Z., et al. Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer. Biomaterials 2013, 34:4109-4117.
55. Goodman T.T., et al. 3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers. Bioconjug. Chem. 2008, 19:1951-1959.
56. Li Z., et al. Association of CXCR1 and 2 expressions with gastric cancer metastasis in ex vivo and tumor cell invasion in vitro. Cytokine 2014, 69:6-13.
57. Lee M.Y., et al. Three-dimensional cellular microarray for high-throughput toxicology assays. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:59-63.
58. Mehling A., et al. Non-animal test methods for predicting skin sensitization potentials. Arch. Toxicol. 2012, 86:1273-1295.
59. Meli L., et al. Influence of a three-dimensional, microarray environment on human cell culture in drug screening systems. Biomaterials 2012, 33:9087-9096.
60. Rangarajan A., Weinberg R.A. Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice. Nat. Rev. Cancer 2003, 3:952-959.
61. Yamada K.M., Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130:601-610.
62. Hao C., et al. Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. Cancer Lett. 2015, 357:179-185.
63. Hwu D., et al. Assessment of the role of circulating breast cancer cells in tumor formation and metastatic potential using in vivo flow cytometry. J. Biomed. Opt. 2011, 16. 040501-040501-3.
64. Liang Y. A cell-instructive hydrogel to regulate malignancy of 3D tumor spheroids with matrix rigidity. Biomaterials 2011, 31:9308-9315.
65. Grimes D.R., et al. A method for estimating the oxygen consumption rate in multicellular tumour spheroids. J. R. Soc. Interface 2014, 11:20131124.
66. Gatenby R.A., et al. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br. J. Cancer. 2007, 97:646-653.
67. Kazmi N., et al. Avascular tumour growth dynamics and the constraints of protein binding for drug transportation. J. Theor. Biol. 2012, 313:142-152.
68. Tredan O., et al. Drug resistance and the solid tumor microenvironment. J. Natl. Cancer Inst. 2007, 99:1441-1454.
69. Fennema E., et al. Spheroid culture as a tool for creating 3D complex tissues. Trends Biotechnol. 2013, 31:108-115.
70. Tung Y.C., et al. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst 2011, 136:473-478.
71. Orlandi P., et al. Idarubicin and idarubicinol effects on breast cancer multicellular spheroids. J. Chemother. 2005, 17:663-667.
72. Clarke M.F., Fuller M. Stem cells and cancer: two faces of eve. Cell 2006, 124:1111-1115.
73. Reya T., et al. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
74. Wang Y.C., et al. Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells. PLoS ONE 2013, 8:e74538.
75. Jung P., et al. Isolation and in vitro expansion of human colonic stem cells. Nat. Med. 2011, 17:1225-1227.
76. Shim M.S., et al. A bioreducible polymer for efficient delivery of Fas-silencing siRNA into stem cell spheroids and enhanced therapeutic angiogenesis. Angew. Chem. Int. Ed. Engl. 2012, 51:11899-11903.
77. Benton G., et al. Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells. Int. J. Cancer 2011, 128:1751-1757.
78. Yeung T.M., et al. Cancer stem cells from colorectal cancer-derived cell lines. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3722-3727.
79. Chen L., et al. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials 2012, 33:1437-1444.
80. Yip D., Cho C.H. A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing. Biochem. Biophys. Res. Commun. 2013, 433:327-332.
81. Mosesson M.W. Fibrinogen and fibrin structure and functions. J. Thromb. Haemost. 2005, 3:1894-1904.
82. Rao S.S., et al. Glioblastoma behaviors in three-dimensional collagen-hyaluronan composite hydrogels. ACS Appl. Mater. Interfaces 2013, 5:9276-9284.
83. Xu X., et al. Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids. Biomaterials 2012, 33:9049-9060.
84. Berger J., et al. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm. 2004, 57:19-34.
85. Florczyk S.J., et al. 3D porous chitosan-alginate scaffolds: a new matrix for studying prostate cancer cell-lymphocyte interactions in vitro. Adv. Healthc. Mater. 2012, 1:590-599.
86. Kievit F.M., et al. Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment. Biomaterials 2010, 31:5903-5910.
87. Fischbach C., et al. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:399-404.
88. Xu X.X., et al. Encapsulated human hepatocellular carcinoma cells by alginate gel beads as an in vitro metastasis model. Exp. Cell Res. 2013, 319:2135-2144.
89. Nyga A., et al. 3D tumour models: novel in vitro approaches to cancer studies. J. Cell Commun. Signal. 2011, 5:239-248.
90. Serebriiskii I., et al. Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells. Matrix Biol. 2008, 27:573-585.
91. Talukdar S., Kundu S.C. A non-mulberry silk fibroin protein based 3D in vitro tumor model for evaluation of anticancer drug activity. Adv. Funct. Mater. 2012, 22:4778-4788.
92. Xu G., et al. In vitro ovarian cancer model based on three-dimensional agarose hydrogel. J. Tissue Eng. 2014, 5. 2041731413520438.
93. Gill B.J., et al. A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model. Cancer Res. 2012, 72:6013-6023.
94. Ki C.S., et al. Effect of 3D matrix compositions on the efficacy of EGFR inhibition in pancreatic ductal adenocarcinoma cells. Biomacromolecules 2013, 14:3017-3026.
95. Fischbach C., et al. Engineering tumors with 3D scaffolds. Nat. Methods 2007, 4:855-860.
96. Ho W.J., et al. Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs. Cancer Sci. 2010, 101:2637-2643.
97. Fong E.L., et al. Modeling Ewing sarcoma tumors in vitro with 3D scaffolds. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:6500-6505.
98. Huang H., et al. Peptide hydrogelation and cell encapsulation for 3D culture of MCF-7 breast cancer cells. PLoS ONE 2013, 8:e59482.
99. Xu X., et al. Three-dimensional in vitro tumor models for cancer research and drug evaluation. Biotechnol. Adv. 2014, 32:1256-1268.
100. Yang Z., Zhao X. A 3D model of ovarian cancer cell lines on peptide nanofiber scaffold to explore the cell-scaffold interaction and chemotherapeutic resistance of anticancer drugs. Int. J. Nanomed. 2011, 6:303-310.
101. Song J.W., et al. Microfluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells. PLoS ONE 2009, 4:e5756.
102. Bischel L.L., et al. Tubeless microfluidic angiogenesis assay with three-dimensional endothelial-lined microvessels. Biomaterials 2013, 34:1471-1477.
103. Bray L.J., et al. Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumour angiogenesis. Biomaterials 2015, 53:609-620.
104. Zheng C., et al. Quantitative study of the dynamic tumor-endothelial cell interactions through an integrated microfluidic coculture system. Anal. Chem. 2012, 84:2088-2093.